Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
AZD4604 racemate | C28H31F2N7O4S | CID 135240362 - PubChem
AZD4604 | Excenen PharmaTech
Azd4604 – Application in Therapy and Current Clinical Research
Dose-response curves of AZD0449 and AZD4604 showing mean (A) inhibition ...
Summary of IC 50 s of AZD0449 and AZD4604 in Human and Rat Leukocytes ...
Physical and Biochemical Properties of AZD0449 and AZD4604 | Download ...
Study on the Effectiveness and Safety of AZD4604 for Adults with ...
Inhibition of STAT3 activation by AZD0449 and AZD4604 (A) in ...
Intratracheal dosing of AZD0449 and AZD4604 showing inhibition of lung ...
Estudio sobre el efecto de AZD4604 en adultos con asma
AZD4604 for Asthma Clinical Trial 2024 | Power
Study on the Effects of AZD4604 on Airway Inflammation in Adults with ...
Phase 2a Study to Assess the Efficacy and Safety of AZD4604 in Adult ...
AZD4604
AZD4604|CAS 2241039-81-4|DC Chemicals
药渡Cyber解析阿斯利康开发JAK1抑制剂AZD4604分子设计和优化详解 - 知乎
九月活性分子速递③: CC-92480，Dalcetrapib，Tovorafenib与AZD4604 - 知乎
Practical and Scalable Method for Manufacturing AZD4604, A Potent and ...
AstraZeneca reports Phase I clinical trial of inhaled JAK1 inhibitor ...
一种JAK1抑制剂AZD4604的制备方法与流程
Characterization of Selective and Potent JAK1 Inhibitors Intended for ...
阿斯利康报道临床I期吸入型JAK1抑制剂AZD4604|JAK1|阿斯利康|吸入型|抑制剂|化合物|临床|报道|哮喘|细胞|气道|药物|因子|-健康界
Londamocitinib (AZD4604) | JAK1 Inhibitor | MedChemExpress
Discovery of the Potent and Selective Inhaled Janus Kinase 1 Inhibitor ...
突破Suzuki偶联区域选择性难题！AZD4604工艺开发中的化学智慧解析 – 微精选
AstraZeneca’s AZD4604: Promising Results in Asthma Treatment Study ...
AZD4604, An Inhaled, Selective JAK1 Inhibitor Reduces Fractional ...
Londamocitinib | JAK | TargetMol
Organic Process Research & Development | Vol 27, No 7
Articles in Press: Journal of Allergy and Clinical Immunology
阿斯利康报道临床I期吸入型JAK1抑制剂AZD4604 - 知乎
Total lung and plasma concentrations after a single intratracheal dose ...
CC-92480、Dalcetrapib、Tovorafenib与AZD4604-新闻动态-上海阿拉丁生化科技股份有限公司
Londamocitinib (AZD4604; JAK1-IN-7) | CAS 2241039-81-4 | AbMole ...
First Disclosures of Small Molecule Drug Candidates – EFMC-ISMC 2021
CC-92480、Dalcetrapib、Tovorafenib与AZD4604
Arvind pithani on LinkedIn: Practical and Scalable Method for ...
Vandetanib, AZD-6474, ZD-6474-药物合成数据库
Drug Hunter - drug discovery, distilled
Comparative safety of oral Janus kinase inhibitors versus dupilumab in ...
Late Breaking Abstract - Distinct effects of londamocitinib, AZD6793 ...
Full article: Characterization of Selective and Potent JAK1 Inhibitors ...
FDA approves Enhertu with pertuzumab for certain HER2-positive breast ...
PROTAC非肿瘤领域突破：以Kymera专利分子为例的STAT6降解剂体外评价体系指南医药新闻-ByDrug-一站式医药资源共享中心-医药魔方
Julien Lefranc posted on LinkedIn
Schematic of AZD0466 drug substance and drug product process. A ...
Small molecule AZD4635 inhibitor of A2AR signaling rescues immune cell ...
AMD-7049(free base), AMD-8664-药物合成数据库
“The ‘Ten Commandments’ of the 2022 ESC/ERS Guidelines for the ...
Efficacy and Safety of Oral Janus Kinase 1 Inhibitor Abrocitinib for ...
Study of Cabozantinib and Avelumab for Patients with Advanced ...
Study on the Effectiveness and Safety of Iptacopan with Drug ...
Computational Study on New Natural Compound Inhibitors of Pyruvate ...
Study Comparing Fluciclovine (18F) and Fluoroethyltyrosine F-18 PET ...
Study on Reducing Antibiotic Duration for Patients with Complicated ...
Study on MK-7684A and Docetaxel for Treating Metastatic Non-Small Cell ...
Study on the Safety and Effectiveness of Polatuzumab Vedotin with ...
Study Comparing Thiamazole and Sodium Iodide (131I) for Treating ...
Sodium Iodide (131I) – Application in Therapy and Current Clinical Research
Study on the Safety and Effectiveness of Pozelimab and Cemdisiran for ...
AZD8205（B7-H4 ADC）联合AZD5305的临床前研究 - 平头哥
